Feedback / Questions
Breztri Aerosphere (budesonide/formoterol fumarate/glycopyrronium) - AstraZeneca
Breztri Aerosphere: Data from P3 THARROS trial (NCT06283966) for COPD post 2025
(AstraZeneca)
-
Nov 12, 2024 -
Q3 2024 Results
P3 data
•
Chronic Obstructive Pulmonary Disease
https://www.astrazeneca.com/content/astraz/investor-relations/9m-and-q3-2024-results-event.html
Nov 12, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious